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Introduction 
Because the morbidity and mortality after treatment 
of an established vascular infection is prohibitively 
high, prevention of local infection should be the prim- 
ary aim, especially if a prosthetic graft has to be used. 
Once the infection has occurred, the infected graft 
must usually be removed. Extra-anatomic bypass or 
autograft replacement with arterial or venous conduits 
are frequently used for revascularisation of on-viable 
organs or extremities. Recently in situ implantation of
allografts or prosthetic grafts has been considered as 
a possible alternative inhigh risk patients or in patients 
with poor run-off if complex secondary re- 
vascularisation was not feasible. I-5 Many methods have 
been described to create an infection-resistant graft, 
binding various antibacterial substances to the vas- 
cular prostheses. 6-11 This paper documents our clinical 
experience with the rifampicin-bonded graft. 
Eight patients were operated on as an emergency. 
Seven patients had total graft replacement and four 
partial replacement of the graft for infection limited 
to the groin (Fig. 1). 
The treatment consisted of parenteral antibiotic 
treatment with oxacillin, accurate skin preparation, 
graft removal, generous wound debridement and local 
antiseptic treatment with betadine. After gloves and 
instruments had been changed a new gelatine-coated 
Dacron prosthesis was soaked with 600 mg rifampicin 
diluted with 10 ml NaC1 0.9% for 10-15 min before 
implantation. If residual contamination could not be 
excluded, continuous irrigation of the wound with 
betadine for 48-72 h was performed. All patients re- 
ceived postoperative intravenous antibiotics on the 
basis of the sensitivities. Bacteriological studies of the 
removed prosthesis howed Staphylococcus aureus in 
eight cases and Staphylococcus epidermidis n four. 
Materials and Methods 
Results 
Between May 1991 and December 1995, 12 patients 
with vascular infection were treated using in situ im- 
plantation of rifampicin-soaked grafts at our in- 
stitution. Eight patients had previous vascular 
reconstruction performed at our department and three 
were previously operated elsewhere. One patient on 
haemodialysis for end-stage renal disease developed 
a mycotic thoracic aneurysm of the descending aorta. 
The mean age of the nine men and three women was 
70 years. The aortic or iliac graft were implanted for 
occlusive disease in 10 cases. The proximal ana- 
stomosis of the infected graft was end-to-end at the 
aorta and end-to-side at the iliac and femoral artery. 
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The patient treated for mycotic thoracic aneurysm had 
to be reoperated for contralatera~ pyothorax and died 
because of sepsis 2 months later. There were two late 
deaths, due to myocardial infarction 10 and 18 months 
after the procedure. After a mean follow-up of 33 
months (range: 6-53 months) only one recurrence was 
found in a case with late graft infection following 
aortofemoral bypass graft with septic bleeding. The 
isolated micro-organism was S. aureus stem resistant 
to both rifampicin and oxacillin. Eight patients howed 
no signs of infection on follow-up. The ankle pressure 
index ranged between 0.5 and 0.9 and no amputations 
were necessary. The first case treated by this technique 
for aneurysm of the visceral aorta and described in 
detail elsewhere 5 is still alive and shows no signs of 
recurrent infection 53 months after the original in situ 
reconstruction (Fig. 2). 
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Fig. 1. Sinography (a) performed in a patient with infection after implantation of a  aortofemoral bifurcation graft and emorocrural 
PTFE-bypass with a postoperative infection limited to the right groin. The preoperative arteriography (b) shows occlusion f the 
femorocrural bypass and a poor run-off. The follow-up CT scan (c) performed after interposition of the gelatine-sealed rifampicin-soaked 
Dacron graft between the original dacron prosthesis and the deep femoral artery shows no more signs of infection. 
Discussion 
Since graft-related infection is caused by irreversible 
adherence of the bacteria to the prosthetic surface, 12 
the standard management  protocol includes complete 
removal of graft material and revascularisation of 
viable extremities and organs by extra-anatomical by- 
pass. In some cases this classical regimen is not feasible. 
Because of possible residual colonisation of the wound,  
in situ implantation of a new graft has been considered 
hazardous. Nevertheless, an increasing number  of 
authors report successful revascularisation using 
allografts 13 and prosthetic grafts 1-4'12'14-16 implanted in 
the original wound in cases which are not feasible 
to be treated by extra-anatomical or autologous 
reconstruction. 
To increase the resistance of grafts to the infection 
several methods of bonding antibiotics to the vascular 
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freshly harvested, not cryopreserved arterial ho- 
mograft) 3 
In a recent report published in this journal, 3Naylor 
et al. summarised the various management options 
in the treatment of major aortic graft infection. The 
multiplicity of alternative procedures (conservative s. 
total graft excision, extra-anatomical vs. anatomical 
vascular econstruction) and of different grafts used 
(artery, vein, allografts, prosthesis with and without 
antibiotic bonding or gentamycin beads/sponge) 
shows the great efforts used to manage the difficult 
problem of vascular graft infection. A retrospective 
analysis of 99 patients operated at our institution 
during a 12-year period 2~ showed apostoperative mor- 
tality rate of 37% 1 year after treatment for prosthetic 
graft infection. This persistent unfavourable outcome 
points out the importance of infection prophylaxis in 
vascular surgery. 
Conclusions 
The reports of other authors and our own experience 
with new techniques show that the in situ technique 
using an antibiotic-bonded graft can be an effective 
strategy with good mid-term results. The potential 
problems connected with extra-anatomical re- 
constructions (prolonged operative time, graft throm- 
bosis, need for anticoagulants, impotence) may result 
in a more liberal use of this operative strategy in the 
future but further studies are required. 
Fig. 2. Postoperative lateral angiography (a) and follow-up CT scan 
carried out 2.5 years after implantation ofa bifurcation graft between 
the subdiaphragmatic aorta and both renal arteries for infected 
aortic stump aneurysm. The coeliac and superior mesenteric artery 
were reimplanted into the graft. The CT scan (b) shows a complete 
resorption of the abscess cavity, the good perfusion of both kidneys 
and the patent axillofemoral bypass graft. 
grafts have been described. 7-1°'17 The easiest method 
used is soaking of the graft simply by dipping it into 
a antibiotic solution. As rifampicin bonds particularly 
well to the gelatine coating on vascular grafts and 
is effective against staphylococcus and many Gram- 
negative micro-organisms, this antibiotic has been 
used in several experimental nd clinical studies for 
prophylaxis or treatment of vascular graft infec- 
tion3 '18-2° Our earlier experience with the use of te- 
icoplanin for soaking a non-sealed Dacron graft was 
negative, showing no adequate control of residual 
bacterial colonisation. Nine months after implantation 
of a teicoplanin-soaked bypass graft the patient ex- 
perienced a recurrent infection. He was treated suc- 
cessfully by aortofemoral graft replacement with 
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